Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis
The Lancet Gastroenterology & Hepatology in conversation with - Un pódcast de The Lancet Group
Categorías:
Rupert Leong (University of Sydney) discusses a new double-blind, randomised, placebo-controlled trial of oral faecal microbiota transplantation for patients with active ulcerative colitis. Read the full article: Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS) Continue this conversation on social! Follow us today at... https://bsky.app/profile/lancetgastrohep.bsky.social https://www.linkedin.com/company/langastro/ https://instagram.com/thelancetgroup ht...
